Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Internal Medicine · SAN JUAN, PR · NPI 1962576793
Verified facts
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
We did not find matching Open Payments records for this doctor in the selected program year.
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1014 | 159 |
| Losartan Potassium | Losartan Potassium | 706 | 102 |
| Metformin Hcl | Metformin Hcl | 637 | 96 |
| Synthroid | Levothyroxine Sodium | 478 | 67 |
| Metoprolol Succinate | Metoprolol Succinate | 468 | 73 |
| Famotidine | Famotidine | 422 | 70 |
| Amlodipine Besylate | Amlodipine Besylate | 417 | 64 |
| Gabapentin | Gabapentin | 411 | 66 |
| Levothyroxine Sodium | Levothyroxine Sodium | 364 | 61 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 338 | 61 |
| Alendronate Sodium | Alendronate Sodium | 331 | 50 |
| Montelukast Sodium | Montelukast Sodium | 286 | 43 |
| Simvastatin | Simvastatin | 283 | 43 |
| Pantoprazole Sodium | Pantoprazole Sodium | 263 | 49 |
| Lisinopril | Lisinopril | 244 | 40 |
| Glimepiride | Glimepiride | 231 | 38 |
| Hydrochlorothiazide | Hydrochlorothiazide | 229 | 38 |
| Ezetimibe | Ezetimibe | 220 | 32 |
| Candesartan Cilexetil | Candesartan Cilexetil | 205 | 25 |
| Clopidogrel | Clopidogrel Bisulfate | 203 | 37 |
| Farxiga | Dapagliflozin Propanediol | 172 | 24 |
| Eliquis | Apixaban | 166 | 27 |
| Omeprazole | Omeprazole | 166 | 24 |
| Tamsulosin Hcl | Tamsulosin Hcl | 157 | 31 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 111 | 16 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 102 | 19 |
| Enalapril Maleate | Enalapril Maleate | 98 | 15 |
| Carvedilol | Carvedilol | 96 | 15 |
| Warfarin Sodium | Warfarin Sodium | 96 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 95 | 31 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 94 | 12 |
| Sertraline Hcl | Sertraline Hcl | 85 | 14 |
| Fluticasone Propionate | Fluticasone Propionate | 82 | 24 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 80 | 15 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 79 | 16 |
| Furosemide | Furosemide | 77 | 19 |
| Irbesartan | Irbesartan | 72 | 13 |
| Fenofibric Acid | Fenofibric Acid (Choline) | 70 | 12 |
| Spironolactone | Spironolactone | 68 | 14 |
| Metoprolol Tartrate | Metoprolol Tartrate | 67 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 66 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 62 | 11 |
| Clonazepam | Clonazepam | 58 | 11 |
| Memantine Hcl | Memantine Hcl | 56 | 12 |
| Atenolol | Atenolol | 55 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 53 | 17 |
| Pravastatin Sodium | Pravastatin Sodium | 53 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 52 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 52 | 11 |
| Jardiance | Empagliflozin | 52 | suppressed |
| Allopurinol | Allopurinol | 51 | suppressed |
| Anastrozole | Anastrozole | 51 | suppressed |
| Xarelto | Rivaroxaban | 46 | suppressed |
| Lansoprazole | Lansoprazole | 44 | suppressed |
| Digoxin | Digoxin | 43 | suppressed |
| Finasteride | Finasteride | 39 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 39 | suppressed |
| Pregabalin | Pregabalin | 38 | suppressed |
| Sucralfate | Sucralfate | 38 | 11 |
| Diclofenac Sodium | Diclofenac Sodium | 37 | 11 |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 37 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 37 | suppressed |
| Tradjenta | Linagliptin | 36 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 35 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 34 | suppressed |
| Nabumetone | Nabumetone | 34 | suppressed |
| Alprazolam | Alprazolam | 33 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 33 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 33 | 22 |
| Ramipril | Ramipril | 33 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 32 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 32 | suppressed |
| Latanoprost | Latanoprost | 31 | suppressed |
| Levetiracetam | Levetiracetam | 31 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 30 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 30 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 28 | suppressed |
| Mupirocin | Mupirocin Calcium | 28 | 20 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 26 | suppressed |
| Nifedipine Er | Nifedipine | 26 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 25 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 25 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 25 | suppressed |
| Azithromycin | Azithromycin | 24 | 24 |
| Insulin Syringe | Syring-Needl,disp,insul,0.3 Ml | 24 | suppressed |
| Chlorthalidone | Chlorthalidone | 23 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 23 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 23 | 21 |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 22 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 22 | suppressed |
| Humalog | Insulin Lispro | 21 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 21 | suppressed |
| Xigduo Xr | Dapaglifloz Propaned/Metformin | 21 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 20 | suppressed |
| Baclofen | Baclofen | 19 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 19 | suppressed |
| Lumigan | Bimatoprost | 18 | suppressed |
| Methylprednisolone | Methylprednisolone | 18 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 17 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 17 | 17 |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 17 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 17 | suppressed |
| Prednisone | Prednisone | 17 | suppressed |
| Timolol Maleate | Timolol Maleate | 17 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 16 | suppressed |
| Galantamine Er | Galantamine Hbr | 16 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 16 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 16 | suppressed |
| Temazepam | Temazepam | 16 | suppressed |
| Humalog Mix 75-25 | Insulin Lispro Protamin/Lispro | 15 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 15 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 15 | suppressed |
| Candesartan-Hydrochlorothiazid | Candesartan/Hydrochlorothiazid | 14 | suppressed |
| Clobetasol Emollient | Clobetasol Propionate/Emoll | 14 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 14 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 14 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 14 | suppressed |
| Gemfibrozil | Gemfibrozil | 14 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 14 | suppressed |
| Rivastigmine | Rivastigmine | 14 | suppressed |
| Carbamazepine Er | Carbamazepine | 13 | suppressed |
| Glipizide | Glipizide | 13 | suppressed |
| Januvia | Sitagliptin Phosphate | 13 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 13 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 13 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 13 | suppressed |
| Verapamil Er | Verapamil Hcl | 13 | suppressed |
| Bupropion Xl | Bupropion Hcl | 12 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 12 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 11 | suppressed |
| Desonide | Desonide | 11 | suppressed |
| Levalbuterol Tartrate Hfa | Levalbuterol Tartrate | 11 | suppressed |
| Pentoxifylline | Pentoxifylline | 11 | suppressed |
| Telmisartan | Telmisartan | 11 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error